Impact of maintaining serum potassium concentration ≥ 3.6mEq/L versus ≥ 4.5mEq/L for 120 hours after isolated coronary artery bypass graft surgery on incidence of new onset atrial fibrillation: Protocol for a randomized non-inferiority trial.
Niall G CampbellElizabeth AllenRichard EvansZahra JamalCharles OpondoJulie SandersJoanna SturgessHugh E MontgomeryDiana ElbourneBenjamin O'BrienPublished in: PloS one (2024)
ClinicalTrials.gov Identifier: NCT04053816. Registered on 13 August 2019. Last update 7 January 2021.
Keyphrases
- coronary artery bypass
- percutaneous coronary intervention
- atrial fibrillation
- study protocol
- randomized controlled trial
- phase iii
- risk factors
- clinical trial
- catheter ablation
- oral anticoagulants
- phase ii
- left atrial
- left atrial appendage
- acute coronary syndrome
- heart failure
- coronary artery disease
- direct oral anticoagulants
- open label
- minimally invasive
- venous thromboembolism
- left ventricular
- double blind